| Authors: |
Sester LS; Amyloidosis Center and Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg., Milani P; Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, and the Department of Molecular Medicine, University of Pavia, Pavia., Theodorakakou F; School of Medicine, National and Kapodistrian University of Athens, Athens., Dittrich T; Amyloidosis Center and Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg., Beimler J; Medical Department of Nephrology, Heidelberg University Hospital, Heidelberg., Aus dem Siepen F; Medical Department of Cardiology, Heidelberg University Hospital, Heidelberg., Zeier M; Medical Department of Nephrology, Heidelberg University Hospital, Heidelberg., Raab MS; Amyloidosis Center and Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg., Müller-Tidow C; Amyloidosis Center and Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg., Kastritis E; School of Medicine, National and Kapodistrian University of Athens, Athens., Palladini G; Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, and the Department of Molecular Medicine, University of Pavia, Pavia., Hegenbart U; Amyloidosis Center and Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg., Schönland SO; Amyloidosis Center and Internal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg. stefan.schoenland@med.uni-heidelberg.de. |
